PPI Lawsuit: Who Qualifies, Payouts, and Filing Deadlines

If you took Nexium, Prilosec, Prevacid, or another proton pump inhibitor for an extended period and later developed kidney disease, stomach cancer, or certain bone fractures, you may be able to file a PPI lawsuit against the drug’s manufacturer. Thousands of these claims are already moving through federal court, and new cases can still be filed in state court or as individual federal actions. Payouts in resolved cases have generally ranged from roughly $25,000 for documented acute kidney injury up to $300,000 or more for kidney failure requiring dialysis or transplant. AstraZeneca agreed in October 2023 to pay $425 million to resolve about 11,000 federal claims over Nexium and Prilosec, and more than 11,000 cases remain active as of late 2025.1United States District Court District of New Jersey. Proton-Pump MDL 2789

Who Can File a Claim

The lawsuits target the most widely used prescription and over-the-counter PPIs. The core defendants and drugs are:

  • AstraZeneca, for Nexium (esomeprazole) and Prilosec (omeprazole)
  • Takeda Pharmaceuticals, for Prevacid (lansoprazole) and Dexilant (dexlansoprazole)
  • Wyeth Pharmaceuticals, a Pfizer subsidiary, for Protonix (pantoprazole)

Takeda alone faced more than 6,600 product liability lawsuits over Prevacid and Dexilant as of early 2021.2U.S. Securities and Exchange Commission. Takeda Pharmaceutical Company Limited – Disclosure of Other Provisions, Contingent Liabilities and Contingent Assets Both prescription and over-the-counter use can support a claim; where no doctor stood between you and the product, the failure-to-warn argument is actually stronger because the label was the only safety information you ever saw.

Kidney injuries drive most of the litigation. A 2016 study in JAMA Internal Medicine found PPI users had roughly 1.5 times the risk of chronic kidney disease compared with people who never used the drugs.3JAMA Network. Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease The injuries that typically qualify:

The usage pattern matters as much as the diagnosis. Most of the scientific evidence linking PPIs to kidney injury involves daily use over months or years. Six months of documented use is generally treated as a baseline. Two weeks of occasional Prilosec for a rough stretch of heartburn is not the same case as three years of daily use ending in a kidney failure diagnosis.

What Your Case May Be Worth

Compensation turns on how severe the injury is, how long you took the drug, and how clean your medical records are. Reported ranges in PPI settlements fall into rough tiers:

  • End-stage renal disease or kidney failure: $150,000 to $300,000 or more
  • Chronic kidney disease, stages 3 through 5: $75,000 to $150,000
  • Acute interstitial nephritis: $50,000 to $100,000
  • Documented acute kidney injury: $25,000 to $75,000
  • Mild or early-stage CKD: evaluated case-by-case, usually on the lower end

These are estimates, not guarantees. Cases that end in dialysis or transplant land at the top of their range because the ongoing medical costs by themselves are enormous. Recoverable damages generally cover past and future medical expenses, lost income, costs of long-term care or lifestyle changes if you are disabled, and non-economic damages for pain, suffering, and reduced quality of life. Punitive damages may be available where a manufacturer’s conduct was especially egregious, though courts apply constitutional limits on how large those awards can be relative to the actual harm.

How Long You Have to File

Every state sets its own statute of limitations for product liability. Most give you two to three years; a few go up to four or six. Miss the deadline and the claim is gone, no matter how strong it would have been. This is the single most common way valid pharmaceutical claims get forfeited.

The harder question is when the clock starts. Nearly every state recognizes the “discovery rule,” which delays the start of the limitations period until you knew, or reasonably should have known, that you were injured and that the injury was linked to the drug. Only about five states reject the rule outright. For PPI cases this matters because kidney disease develops slowly and patients rarely connect it to their heartburn medication without being told. If you were diagnosed in 2024 and only learned in 2025 that PPIs might be the cause, the clock most likely started in 2025.

The standard is not purely subjective, though. A court will hold you to what a reasonable person would have figured out with basic investigation. If your doctor flagged a possible medication link in 2023 and you waited until 2026, a judge may find the deadline already ran.

Some states also impose a statute of repose, a hard outer deadline measured from the manufacturer’s conduct (such as when the drug was sold). A repose period can expire before you even know you were hurt, and no amount of delayed discovery overrides it. Checking your state’s specific deadlines with a lawyer early, before gathering records or anything else, is worth doing.

Evidence You Will Need

A PPI claim requires proof on two tracks: that you used the drug, and that it caused the injury. The more specific your records, the harder it is for the defense to pick the case apart.

  • Medical records showing when you were diagnosed with kidney disease, stomach cancer, or a qualifying fracture, with a timeline that starts after PPI use began
  • Pharmacy fill histories showing which PPI, what dose, and for how long
  • For over-the-counter use, receipts, store loyalty card data, or credit card statements showing pharmacy purchases
  • Insurance explanation-of-benefits statements covering both the prescriptions and the related medical visits

If your case is folded into the federal MDL, you will complete a Plaintiff Fact Sheet, a standardized questionnaire covering your health history, doctors, pharmacies, PPI usage, prior litigation, and supporting documents.6United States District Court District of New Jersey. Case Management Order No. 9 – Plaintiff Fact Sheet and PFS Document Production You will also sign authorizations letting the defense pull your medical and pharmacy records directly. Accuracy matters: incomplete or inconsistent fact sheets can get a case dismissed or deprioritized.

Record retrieval tends to take longer than people expect. Providers charge per-page fees, and response times vary. Starting early gives your legal team room to spot gaps before any filing deadline hits.

What Filing a PPI Lawsuit Looks Like

Most federal PPI cases are consolidated in Multidistrict Litigation No. 2789 in the U.S. District Court for the District of New Jersey, established by the Judicial Panel on Multidistrict Litigation in August 2017.1United States District Court District of New Jersey. Proton-Pump MDL 2789 The initial transfer order grouped 161 personal injury and wrongful death actions alleging chronic kidney disease, acute interstitial nephritis, end-stage renal disease, and kidney failure from PPI use.7United States Judicial Panel on Multidistrict Litigation. MDL No. 2789 – In Re Proton-Pump Inhibitor Products Liability Litigation (No. II) That number has since grown past 11,000.

Consolidation does not merge the cases into one lawsuit. Each plaintiff keeps an individual claim with individual damages. What the MDL does is decide the shared legal questions once rather than thousands of times. Cases that do not settle are supposed to go back to their home districts for individual trials, though in practice MDLs this size almost always resolve through settlement.

The core legal theory is failure to warn. Plaintiffs argue the manufacturers knew or should have known about the kidney risk and had a duty to update their labels as the evidence built up. For prescription drugs, that duty runs to the prescribing physician; for over-the-counter sales, it runs to the consumer through the label itself. Many plaintiffs add a negligence count built on the same facts.

Filing itself is straightforward on your end: your attorney drafts the complaint, submits it with your Plaintiff Fact Sheet through the court’s electronic filing system, and your case enters the MDL workflow. The timeline from filing to resolution typically stretches for years.

What It Costs to Hire a Lawyer

PPI cases are handled on contingency. You pay nothing upfront, and your attorney takes a percentage of whatever you recover; if the case produces nothing, you owe no legal fees. The standard contingency rate for personal injury work is around 33 percent, though it varies by firm and some use sliding scales tied to the recovery amount.

Case costs (filing fees, medical record retrieval, expert witnesses, administrative expenses) sit on top of the fee. In mass tort cases, many of these costs are spread across the plaintiff group, which lowers the individual share. Before signing a retainer, ask specifically whether costs come out of your share of the settlement or are deducted before the contingency percentage is calculated. The order of those deductions can swing your net recovery by thousands of dollars.

Who Likely Will Not Qualify

Not every PPI user with kidney problems has a viable claim. The biggest disqualifier is pre-existing kidney disease. If your records show renal problems before you ever started a PPI, proving the drug caused your condition becomes very difficult. The research studies linking PPIs to kidney damage specifically excluded patients with pre-existing renal disease.8National Center for Biotechnology Information. Proton Pump Inhibitors and Risk of Acute and Chronic Kidney Disease – A Retrospective Cohort Study

Short or infrequent use weakens a case too. Someone who took a PPI for two weeks and later developed kidney disease faces a much harder causation argument than someone who took it daily for three years. Other common complications: a known alternative cause for the kidney damage such as uncontrolled diabetes, long-term NSAID use, or certain autoimmune conditions; no documentation of PPI usage in pharmacy or medical records; or a statute of limitations that has already run.

An initial consultation with a mass tort attorney is usually free and will tell you quickly whether your situation has enough merit to pursue or whether the obstacles are too steep.

Where the Litigation Stands Now

AstraZeneca’s $425 million settlement in October 2023 resolved roughly 11,000 federal lawsuits over Nexium and Prilosec. The company did not admit wrongdoing. The deal cleared a large block of pending federal cases but left thousands behind, including cases that opted out, cases filed after the settlement cut-off, and claims against defendants other than AstraZeneca. More than 11,000 cases remain active in the MDL as of late 2025, and no new mass settlement has been announced for 2026. Individual cases continue to move forward in both federal and state courts, and new claims can still be filed, subject to your state’s deadlines.